Netherlands· NL-d92895aa26c8
Norvir 100 mg poeder voor orale suspensie
A ritonavir product containing ritonavir, registered in Netherlands by AbbVie Deutschland GmbH & Co. KG. The same ATC class is registered in 16 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Ritonavir is registered in 16 of 19 countries.
Countries holding a registration under ATC J05AE03 (ritonavir), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 9 of them publish a price we can compare per daily dose
Ritonavir · ATC J05AE03
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ritonavir costs, country by country.
Normalised to the WHO defined daily dose (1.2 g), the median price runs from $4.15 in France to $20.09 in Switzerland — a ×4.8 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ritonavir · price per daily dose (1.2 g)
USD · FX 28 Sept 2026
- CH Switzerland$20.09
- FR France$4.15
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- RITONAVIR
- Manufacturer
- AbbVie Deutschland GmbH & Co. KG
- Country
- Netherlands (NL)
- ATC code
- J05AE03
- ATC class
- Ritonavir
- Defined daily dose
- 1.2 g, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/96/016
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
515 interactions on record for ritonavir.
Graded by severity as the source publishes them — 149 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ritonavir · interactions on record
515 records
- 149 severe
- 238 moderate
- 19 minor
- 66 info
Most severe, free to view
- CisaprideA03FA02severe
- NaloxegolA06AH03severe
- LoperamideA07DA03severe
- EluxadolineA07DA06severe
43 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ritonavir in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumNorvir 100 mgAbbVie Deutschland
- CzechiaNORVIRAbbVie Deutschland GmbH & Co.KG, Ludwigshafen
- SpainNORVIR 100MG POLVO PARA SUSPENSION ORALAbbvie Deutschland Gmbh & Co. Kg
- FinlandNorvirAbbVie Deutschland GmbH&Co.KG
- FranceNORVIR 100 mg, poudre pour suspension buvableABBVIE DEUTSCHLAND (ALLEMAGNE)
- United KingdomNorvir 100mg oral powder sachetsAbbVie Ltd
- IrelandNorvir 100 mg powder for oral suspensionAbbVie Deutschland GmbH & Co. KG
- IcelandNorvirAbbVie Deutschland GmbH & Co. KG
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Austria · Ritonavir Accord
- Belgium · Ritonavir Accord
- Cyprus · Ritonavir Accord
- Germany · Ritonavir Accord, Ritonavir Hexal
- Denmark · Ritonavir Accord
- Estonia · Ritonavir Auxilia
- Spain · Ritonavir Accord
- Finland · Ritonavir Accord
- France · Ritonavir Arrow
- United Kingdom (Northern Ireland) · Norvir, Ritonavir Accord Healthcare
- Hungary · Ritonavir Accord
- Iceland · Norvir, Ritonavir Viatris
- Italy · Ritonavir Sandoz
- Liechtenstein · Norvir, Ritonavir Viatris
- Norway · Norvir, Ritonavir Viatris
- Poland · Ritonavir Accord, Ritonavir Aurovitas
- Portugal · Ritonavir Farmoz, Ritonavir Generis
- Sweden · Ritonavir Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8b39b7b0-c3ae-4723-a1f4-b2237467fceb GET /v1/drugs/8b39b7b0-c3ae-4723-a1f4-b2237467fceb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Poeder voor orale suspensie",
"route": "Oraal gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/norvir-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Ritonavir",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp115565",
"excipients": [
"COPOVIDON (E 1208)",
"SILICIUMDIOXIDE (E 551)",
"SORBITANMONOLAURAAT (E 493)"
],
"substances": [
"RITONAVIR"
],
"leaflet_url": null,
"authorised_at": "1996/08/25",
"procedure_number": "EMEA/H/C/000127",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/96/016",
"additional_monitoring": "N"
}See everything about ritonavir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.